annual cash & cash equivalents:
$92.65M+$46.97M(+102.81%)Summary
- As of today (July 1, 2025), VERA annual cash & cash equivalents is $92.65 million, with the most recent change of +$46.97 million (+102.81%) on December 31, 2024.
- During the last 3 years, VERA annual cash & cash equivalents has risen by +$12.97 million (+16.28%).
- VERA annual cash & cash equivalents is now at all-time high.
Performance
VERA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$55.09M-$37.56M(-40.54%)Summary
- As of today (July 1, 2025), VERA quarterly cash & cash equivalents is $55.09 million, with the most recent change of -$37.56 million (-40.54%) on March 31, 2025.
- Over the past year, VERA quarterly cash & cash equivalents has dropped by -$14.02 million (-20.28%).
- VERA quarterly cash & cash equivalents is now -59.90% below its all-time high of $137.38 million, reached on March 31, 2023.
Performance
VERA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VERA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +102.8% | -20.3% |
| 3 y3 years | +16.3% | -50.6% |
| 5 y5 years | +2799.7% | +1549.7% |
VERA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.2% | -59.9% | +119.6% |
| 5 y | 5-year | at high | +2799.7% | -59.9% | +119.6% |
| alltime | all time | at high | +2799.7% | -59.9% | +1549.7% |
VERA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $55.09M(-40.5%) |
| Dec 2024 | $92.65M(+102.8%) | $92.65M(+239.9%) |
| Sep 2024 | - | $27.26M(+8.7%) |
| Jun 2024 | - | $25.09M(-63.7%) |
| Mar 2024 | - | $69.11M(+51.3%) |
| Dec 2023 | $45.68M(+5.1%) | $45.68M(+66.5%) |
| Sep 2023 | - | $27.44M(-19.0%) |
| Jun 2023 | - | $33.89M(-75.3%) |
| Mar 2023 | - | $137.38M(+216.1%) |
| Dec 2022 | $43.46M | $43.46M(+42.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $30.48M(-39.6%) |
| Jun 2022 | - | $50.43M(-54.8%) |
| Mar 2022 | - | $111.51M(+40.0%) |
| Dec 2021 | $79.67M(+48.5%) | $79.67M(-7.6%) |
| Sep 2021 | - | $86.19M(-5.9%) |
| Jun 2021 | - | $91.63M(+85.1%) |
| Mar 2021 | - | $49.51M(-7.7%) |
| Dec 2020 | $53.65M(+1579.3%) | - |
| Dec 2020 | - | $53.65M(-1511.9%) |
| Mar 2020 | - | -$3.80M |
| Dec 2019 | $3.19M | - |
FAQ
- What is Vera Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vera Therapeutics?
- What is Vera Therapeutics annual cash & cash equivalents year-on-year change?
- What is Vera Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Vera Therapeutics?
- What is Vera Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Vera Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of VERA is $92.65M
What is the all time high annual cash & cash equivalents for Vera Therapeutics?
Vera Therapeutics all-time high annual cash & cash equivalents is $92.65M
What is Vera Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, VERA annual cash & cash equivalents has changed by +$46.97M (+102.81%)
What is Vera Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of VERA is $55.09M
What is the all time high quarterly cash & cash equivalents for Vera Therapeutics?
Vera Therapeutics all-time high quarterly cash & cash equivalents is $137.38M
What is Vera Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, VERA quarterly cash & cash equivalents has changed by -$14.02M (-20.28%)